Cancer: Antioxidants accelerate lung cancer progression in mice

Science Translational Medicine

Volumn 6, Issue 221, 2014, Pages

  Sayin, Volkan I ^a   Ibrahim, Mohamed X ^a   Larsson, Erik ^a   Nilsson, Jonas A ^a   Lindahl, Per ^a   Bergo, Martin O ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; ALPHA TOCOPHEROL; ANTIOXIDANT; DRUG DERIVATIVE; PROTEIN P53; REACTIVE OXYGEN METABOLITE;

ANIMAL; ARTICLE; CELL PROLIFERATION; DISEASE COURSE; DISEASE MODEL; DNA DAMAGE; DRUG EFFECT; FIBROBLAST; HUMAN; LUNG TUMOR; METABOLISM; MOUSE; PATHOLOGY; SOLUBILITY; TUMOR CELL LINE;

ACETYLCYSTEINE; ANIMALS; ANTIOXIDANTS; CELL LINE, TUMOR; CELL PROLIFERATION; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; DNA DAMAGE; FIBROBLASTS; HUMANS; LUNG NEOPLASMS; MICE; REACTIVE OXYGEN SPECIES; SOLUBILITY; TUMOR SUPPRESSOR PROTEIN P53; VITAMIN E;

EID: 84893857285     PISSN: 19466234     EISSN: 19466242     Source Type: Journal    
DOI: 10.1126/scitranslmed.3007653     Document Type: Article

References (41)

1. J. K. Willcox, S. L. Ash, G. L. Catignani, Antioxidants and prevention of chronic disease. Crit. Rev. Food Sci. Nutr. 44, 275-295 (2004).
2. K. Irani, Y. Xia, J. L. Zweier, S. J. Sollott, C. J. Der, E. R. Fearon, M. Sundaresan, T. Finkel, P. J. Goldschmidt-Clermont, Mitogenic signaling mediated by oxidants in Ras-transformed fibroblasts. Science 275, 1649-1652 (1997).
3. A. A. Sablina, A. V. Budanov, G. V. Ilyinskaya, L. S. Agapova, J. E. Kravchenko, P. M. Chumakov, The antioxidant function of the p53 tumor suppressor. Nat. Med. 11, 1306-1313 (2005).
4. O. Vafa, M. Wade, S. Kern, M. Beeche, T. K. Pandita, G. M. Hampton, G. M. Wahl, c-Myc can induce DNA damage, increase reactive oxygen species, and mitigate p53 function: A mechanism for oncogene-induced genetic instability. Mol. Cell 9, 1031-1044 (2002).
5. W. J. Blot, J. Y. Li, P. R. Taylor, W. Guo, S. Dawsey, G. Q. Wang, C. S. Yang, S. F. Zheng, M. Gail, G. Y. Li, Nutrition intervention trials in Linxian, China: Supplementation with specific vitamin/mineral combinations, cancer incidence, and disease-specific mortality in the general population. J. Natl. Cancer Inst. 85, 1483-1492 (1993).
6. The effect of vitamin E and β carotene on the incidence of lung cancer and other cancers in male smokers. The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group. N. Engl. J. Med. 330, 1029-1035 (1994).
7. N. van Zandwijk, O. Dalesio, U. Pastorino, N. de Vries, H. van Tinteren, EUROSCAN, a randomized trial of vitamin A and N-acetylcysteine in patients with head and neck cancer or lung cancer. For the EUropean Organization for Research and Treatment of Cancer Head and Neck and Lung Cancer Cooperative Groups. J. Natl. Cancer Inst. 92, 977-986 (2000).
8. G. Bjelakovic, D. Nikolova, L. L. Gluud, R. G. Simonetti, C. Gluud, Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: Systematic review and meta-analysis. JAMA 297, 842-857 (2007).
9. E. A. Klein, I. M. Thompson Jr., C. M. Tangen, J. J. Crowley, M. S. Lucia, P. J. Goodman, L. M. Minasian, L. G. Ford, H. L. Parnes, J. M. Gaziano, D. D. Karp, M. M. Lieber, P. J. Walther, L. Klotz, J. K. Parsons, J. L. Chin, A. K. Darke, S. M. Lippman, G. E. Goodman, F. L. Meyskens Jr., L. H. Baker, Vitamin E and the risk of prostate cancer: The Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA 306, 1549-1556 (2011).
10. J. Watson, Oxidants, antioxidants and the current incurability of metastatic cancers. Open Biol. 3, 120144 (2013).
11. A. Singh, V. Misra, R. K. Thimmulappa, H. Lee, S. Ames, M. O. Hoque, J. G. Herman, S. B. Baylin, D. Sidransky, E. Gabrielson, M. V. Brock, S. Biswal, Dysfunctional KEAP1-NRF2 interaction in non-small-cell lung cancer. PLOS Med. 3, e420 (2006).
12. Cancer Genome Atlas Research Network, Comprehensive genomic characterization of squamous cell lung cancers. Nature 489, 519-525 (2012).
13. A. Singh, S. Boldin-Adamsky, R. K. Thimmulappa, S. K. Rath, H. Ashush, J. Coulter, A. Blackford, S. N. Goodman, F. Bunz, W. H. Watson, E. Gabrielson, E. Feinstein, S. Biswal, RNAi-mediated silencing of nuclear factor erythroid-2-related factor 2 gene expression in non-small cell lung cancer inhibits tumor growth and increases efficacy of chemotherapy. Cancer Res. 68, 7975-7984 (2008).
14. G. M. DeNicola, F. A. Karreth, T. J. Humpton, A. Gopinathan, C. Wei, K. Frese, D. Mangal, K. H. Yu, C. J. Yeo, E. S. Calhoun, F. Scrimieri, J. M. Winter, R. H. Hruban, C. Iacobuzio-Donahue, S. E. Kern, I. A. Blair, D. A. Tuveson, Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis. Nature 475, 106-109 (2011).
15. R. M. Perera, N. Bardeesy, Cancer: When antioxidants are bad. Nature 475, 43-44 (2011).
16. E. L. Jackson, N. Willis, K. Mercer, R. T. Bronson, D. Crowley, R. Montoya, T. Jacks, D. A. Tuveson, Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras. Genes Dev. 15, 3243-3248 (2001).
17. V600E-induced lung tumors. Genes Dev. 21, 379-384 (2007).
18. V600E. Cancer Res. 72, 3048-3059 (2012).
19. S. J. Bell, G. T. Grochoski, How safe is vitamin E supplementation? Crit. Rev. Food Sci. Nutr. 48, 760-774 (2008).
20. A. M. Sadowska, N-Acetylcysteine mucolysis in the management of chronic obstructive pulmonary disease. Ther. Adv. Respir. Dis. 6, 127-135 (2012).
21. D. Malhotra, E. Portales-Casamar, A. Singh, S. Srivastava, D. Arenillas, C. Happel, C. Shyr, N. Wakabayashi, T. W. Kensler, W. W. Wasserman, S. Biswal, Global mapping of binding sites for Nrf2 identifies novel targets in cell survival response through ChIP-Seq profiling and network analysis. Nucleic Acids Res. 38, 5718-5734 (2010).
22. A. K. Bauer, H. Y. Cho, L. Miller-Degraff, C. Walker, K. Helms, J. Fostel, M. Yamamoto, S. R. Kleeberger, Targeted deletion of Nrf2 reduces urethane-induced lung tumor development in mice. PLOS One 6, e26590 (2011).
23. S. De Flora, M. Astengo, D. Serra, C. Bennicelli, Inhibition of urethan-induced lung tumors in mice by dietary N-acetylcysteine. Cancer Lett. 32, 235-241 (1986).
24. N. van Zandwijk, N-Acetylcysteine for lung cancer prevention. Chest 107, 1437-1441 (1995).
25. C. D. Allred, K. F. Allred, Y. H. Ju, S. M. Virant, W. G. Helferich, Soy diets containing varying amounts of genistein stimulate growth of estrogen-dependent (MCF-7) tumors in a dosedependent manner. Cancer Res. 61, 5045-5050 (2001).
26. M. Cortés-Jofré, J. R. Rueda, G. Corsini-Muñoz, C. Fonseca-Cortés, M. Caraballoso, X. Bonfill Cosp, Drugs for preventing lung cancer in healthy people. Cochrane Database Syst. Rev. 10, CD002141 (2012).
27. C. Robinson, S. Woo, A. Walsh, A. K. Nowak, R. A. Lake, The antioxidants vitamins A and E and selenium do not reduce the incidence of asbestos-induced disease in a mouse model of mesothelioma. Nutr. Cancer 64, 315-322 (2012).
28. E. R. Fearon, B. Vogelstein, A genetic model for colorectal tumorigenesis. Cell 61, 759-767 (1990).
29. S. Marino, M. Vooijs, H. van Der Gulden, J. Jonkers, A. Berns, Induction of medulloblastomas in p53-null mutant mice by somatic inactivation of Rb in the external granular layer cells of the cerebellum. Genes Dev. 14, 994-1004 (2000).
30. A. K. Sjogren, K. M. Andersson, M. Liu, B. A. Cutts, C. Karlsson, A. M. Wahlstrom, M. Dalin, C. Weinbaum, P. J. Casey, A. Tarkowski, B. Swolin, S. G. Young, M. O. Bergo, GGTase-I deficiency reduces tumor formation and improves survival in mice with K-RAS-induced lung cancer. J. Clin. Invest. 117, 1294-1304 (2007).
31. V. I. Sayin, A. Nilton, M. X. Ibrahim, P. Ågren, E. Larsson, M. M. Petit, L. M. Hultén, M. Ståhlman, B. R. Johansson, M. O. Bergo, P. Lindahl, Zfp148 deficiency causes lung maturation defects and lethality in newborn mice that are rescued by deletion of p53 or antioxidant treatment. PLOS One 8, e55720 (2013).
32. A. Y. Nikitin, A. Alcaraz, M. R. Anver, R. T. Bronson, R. D. Cardiff, D. Dixon, A. E. Fraire, E. W. Gabrielson, W. T. Gunning, D. C. Haines, M. H. Kaufman, R. I. Linnoila, R. R. Maronpot, A. S. Rabson, R. L. Reddick, S. Rehm, N. Rozengurt, H. M. Schuller, E. N. Shmidt, W. D. Travis, J. M. Ward, T. Jacks, Classification of proliferative pulmonary lesions of the mouse: Recommendations of the mouse models of human cancers consortium. Cancer Res. 64, 2307-2316 (2004).
33. D. M. Feldser, K. K. Kostova, M. M. Winslow, S. E. Taylor, C. Cashman, C. A. Whittaker, F. J. Sanchez-Rivera, R. Resnick, R. Bronson, M. T. Hemann, T. Jacks, Stage-specific sensitivity to p53 restoration during lung cancer progression. Nature 468, 572-575 (2010).
34. C. Trapnell, L. Pachter, S. L. Salzberg, TopHat: Discovering splice junctions with RNA-Seq. Bioinformatics 25, 1105-1111 (2009).
35. F. Hsu, W. J. Kent, H. Clawson, R. M. Kuhn, M. Diekhans, D. Haussler, The UCSC known genes. Bioinformatics 22, 1036-1046 (2006).
36. M. Liu, A. K. Sjogren, C. Karlsson, M. X. Ibrahim, K. M. Andersson, F. J. Olofsson, A. M. Wahlstrom, M. Dalin, H. Yu, Z. Chen, S. H. Yang, S. G. Young, M. O. Bergo, Targeting the protein prenyltransferases efficiently reduces tumor development in mice with K-RAS-induced lung cancer. Proc. Natl. Acad. Sci. U.S.A. 107, 6471-6476 (2010).
37. A. Höglund, L. M. Nilsson, S. V. Muralidharan, L. A. Hasvold, P. Merta, M. Rudelius, V. Nikolova, U. Keller, J. A. Nilsson, Therapeutic implications for the induced levels of Chk1 in Mycexpressing cancer cells. Clin. Cancer Res. 17, 7067-7079 (2011).
38. M. X. Ibrahim, V. I. Sayin, M. K. Akula, M. Liu, L. G. Fong, S. G. Young, M. O. Bergo, Targeting isoprenylcysteine methylation ameliorates disease in a mouse model of progeria. Science 340, 1330-1333 (2013).
39. S. Anders, W. Huber, Differential expression analysis for sequence count data. Genome Biol. 11, R106 (2010).
40. A. Subramanian, P. Tamayo, V. K. Mootha, S. Mukherjee, B. L. Ebert, M. A. Gillette, A. Paulovich, S. L. Pomeroy, T. R. Golub, E. S. Lander, J. P. Mesirov, Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. U.S.A. 102, 15545-15550 (2005).
41. D. Kenzelmann Broz, S. Spano Mello, K. T. Bieging, D. Jiang, R. L. Dusek, C. A. Brady, A. Sidow, L. D. Attardi, Global genomic profiling reveals an extensive p53-regulated autophagy program contributing to key p53 responses. Genes Dev. 27, 1016-1031 (2013).